Medial Frontal GABA is Lower in Older Schizophrenia: A MEGA-PRESS with Macromolecule Suppression Study

Gamma-butyric acid (GABA) dysfunction has been implicated in the pathophysiology of schizophrenia and its cognitive deficits. Proton magnetic resonance spectroscopy (MRS) was used to test the hypothesis that older participants with schizophrenia have lower anterior cingulate GABA levels compared with older control participants. One-hundred forty-five participants completed this study. For detection of GABA, spectra were acquired from the medial frontal/anterior cingulate cortex using a macromolecule-suppressed MEGA-PRESS sequence. Patients were evaluated for psychopathology and all participants completed neuropsychological tests of working memory, processing speed and functional capacity. GABA levels were significantly lower in the older participants with schizophrenia (n=31) compared with the older control (n=37) group (P=0.003) but not between the younger control (n=40) and schizophrenia (n=29) groups (P=0.994). Age strongly predicted GABA levels in the schizophrenia group accounting for 42% of the variance, but the effect of age was less in the control group accounting for 5.7% of the variance. GABA levels were specifically related to working memory but not processing speed performance, functional capacity, or positive or negative symptom severity. This is the largest MRS study of GABA in schizophrenia and the first to examine GABA without macromolecule contamination, a potentially significant issue in previous studies. GABA levels more rapidly declined with advancing age in the schizophrenia compared with the control group. Interventions targeted at halting the decline or increasing GABA levels may improve functional outcomes and quality of life as patients with schizophrenia age.

[1]  A. Stan,et al.  Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies. , 2012, Current pharmaceutical biotechnology.

[2]  A M McIntosh,et al.  Working memory in schizophrenia: a meta-analysis , 2008, Psychological Medicine.

[3]  R. Fisher.  014: On the "Probable Error" of a Coefficient of Correlation Deduced from a Small Sample. , 1921 .

[4]  Arvind Caprihan,et al.  Use of tissue water as a concentration reference for proton spectroscopic imaging , 2006, Magnetic resonance in medicine.

[5]  J. Mugler,et al.  Three‐dimensional magnetization‐prepared rapid gradient‐echo imaging (3D MP RAGE) , 1990, Magnetic resonance in medicine.

[6]  Peter R Luijten,et al.  Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. , 2013, Schizophrenia bulletin.

[7]  Deanna M. Barch,et al.  Cognition in schizophrenia: core psychological and neural mechanisms , 2012, Trends in Cognitive Sciences.

[8]  S. Woods,et al.  Chlorpromazine equivalent doses for the newer atypical antipsychotics. , 2003, The Journal of clinical psychiatry.

[9]  R. Edden,et al.  Gannet: A batch‐processing tool for the quantitative analysis of gamma‐aminobutyric acid–edited MR spectroscopy spectra , 2014, Journal of magnetic resonance imaging : JMRI.

[10]  Dost Öngür,et al.  Elevated Gamma-Aminobutyric Acid Levels in Chronic Schizophrenia , 2010, Biological Psychiatry.

[11]  S. Kéri,et al.  Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: The potential impact of GABA concentration in the visual cortex , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  D. Glahn,et al.  Dedifferentiation and substitute strategy: Deconstructing the processing-speed impairment in schizophrenia , 2012, Schizophrenia Research.

[13]  A. Sampson,et al.  Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.

[14]  Mark Slifstein,et al.  Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. , 2012, Archives of general psychiatry.

[15]  Junghee Lee,et al.  Working memory impairments in schizophrenia: a meta-analysis. , 2005, Journal of abnormal psychology.

[16]  A. Meyer-Lindenberg,et al.  Absence of changes in GABA concentrations with age and gender in the human anterior cingulate cortex: A MEGA‐PRESS study with symmetric editing pulse frequencies for macromolecule suppression , 2013, Magnetic resonance in medicine.

[17]  Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. , 2010, The American journal of psychiatry.

[18]  J. Gold,et al.  Next-generation negative symptom assessment for clinical trials: Validation of the Brief Negative Symptom Scale , 2012, Schizophrenia Research.

[19]  J. Krystal,et al.  Sex, GABA, and nicotine: The impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy , 2005, Biological Psychiatry.

[20]  E. G. Jones,et al.  Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.

[21]  D. Hines,et al.  Disrupting the clustering of GABAA receptor α2 subunits in the frontal cortex leads to reduced γ-power and cognitive deficits , 2013, Proceedings of the National Academy of Sciences.

[22]  Yogesh K. Dwivedi,et al.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.

[23]  Lars-Göran Nilsson,et al.  Age-related white matter microstructural differences partly mediate age-related decline in processing speed but not cognition. , 2012, Biochimica et biophysica acta.

[24]  Jong H. Yoon,et al.  GABA Concentration Is Reduced in Visual Cortex in Schizophrenia and Correlates with Orientation-Specific Surround Suppression , 2010, The Journal of Neuroscience.

[25]  A. Graff-Guerrero,et al.  Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study. , 2013, JAMA psychiatry.

[26]  Society of magnetic resonance in medicine , 1990 .

[27]  Wenyaw Chan,et al.  Statistical Methods in Medical Research , 2013, Model. Assist. Stat. Appl..

[28]  F. Benes,et al.  GABAergic Interneurons: Implications for Understanding Schizophrenia and Bipolar Disorder , 2001, Neuropsychopharmacology.

[29]  J. J. Ryan,et al.  Wechsler Adult Intelligence Scale-III , 2001 .

[30]  Huiquan Wang,et al.  Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels , 2013, NeuroImage.

[31]  R. Yoshimura,et al.  No alterations of brain GABA after 6months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  D. Barch,et al.  The Cognitive Neuroscience of Working Memory: Relevance to CNTRICS and Schizophrenia , 2008, Biological Psychiatry.

[33]  M. Garwood,et al.  Simultaneous in vivo spectral editing and water suppression , 1998, NMR in biomedicine.

[34]  D. Lewis,et al.  Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.

[35]  H. M. Morris,et al.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2008, Molecular Psychiatry.

[36]  S. A. Wijtenburg,et al.  In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. , 2013, Schizophrenia bulletin.

[37]  D. Dickinson.  Digit symbol coding and general cognitive ability in schizophrenia: worth another look? , 2008, British Journal of Psychiatry.

[38]  Philip D. Harvey,et al.  Is schizophrenia a syndrome of accelerated aging? , 2008, Schizophrenia bulletin.

[39]  W. Cleveland,et al.  Locally Weighted Regression: An Approach to Regression Analysis by Local Fitting , 1988 .

[40]  David A Lewis,et al.  GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia. , 2005, Current neuropharmacology.

[41]  Sarah H. Lisanby,et al.  Neuroimage: Clinical Gaba Level, Gamma Oscillation, and Working Memory Performance in Schizophrenia , 2022 .

[42]  D. R. Curtis,et al.  GABA, Bicuculline and Central Inhibition , 1970, Nature.

[43]  A. Guidotti,et al.  Should allosteric positive modulators of GABAA receptors be tested in the treatment of schizophrenia? , 2005, Schizophrenia Research.

[44]  Randolph C. Arnau,et al.  Second Order Confirmatory Factor Analysis of the WAIS-III , 2000, Assessment.

[45]  Philip D. Harvey,et al.  Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. , 2008, Journal of psychiatric research.

[46]  D. Lewis,et al.  Alterations of Cortical GABA Neurons and Network Oscillations in Schizophrenia , 2010, Current psychiatry reports.

[47]  Peter Kochunov,et al.  Multimodal white matter imaging to investigate reduced fractional anisotropy and its age-related decline in schizophrenia , 2014, Psychiatry Research: Neuroimaging.

[48]  Elisa Conti,et al.  Progress in Neuro-Psychopharmacology & Biological Psychiatry , 2012 .

[49]  E. Bora.  Neurodevelopmental origin of cognitive impairment in schizophrenia , 2014, Psychological Medicine.

[50]  Susan N. Wright,et al.  Accelerated white matter aging in schizophrenia: role of white matter blood perfusion , 2014, Neurobiology of Aging.

[51]  J. Gold,et al.  Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. , 2007, Archives of general psychiatry.

[52]  A. Graff-Guerrero,et al.  Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study. , 2013, The international journal of neuropsychopharmacology.

[53]  Philip D. Harvey,et al.  Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS) , 2008, Schizophrenia Research.

[54]  A. Graff-Guerrero,et al.  Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis , 2011, Neuropsychopharmacology.

[55]  N. Woodward,et al.  Processing speed impairment in schizophrenia is mediated by white matter integrity , 2014, Psychological Medicine.

[56]  D. Jeste,et al.  Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. , 2011, Schizophrenia bulletin.

[57]  G. Bloch,et al.  Brain GABA editing without macromolecule contamination , 2001, Magnetic resonance in medicine.